Microsoft Research introduced Quine on September 29, 2026. The experimental system links a model trained across kinds of biological evidence with scientific tools, literature, and researchers. Its data types include genomic information, proteins, cell states, and images. A researcher can use its computational proposals to choose what to test in a laboratory, then feed measurements into the next research question. Source
What the study tested
In work with the Broad Institute, researchers used Quine to rank compounds predicted to shift the state of pancreatic cancer cells. A compound here means a substance applied to cells during an experiment. Several highly ranked candidates produced the intended shifts in laboratory assays. These are results from research models and cell experiments; the announcement does not report a treatment tested in patients. Source
Access and intended use
Microsoft describes Quine as experimental research technology and explicitly excludes clinical or medical use. Its outputs can be incomplete or inaccurate and need qualified review and further testing. Initial access is limited to selected research collaborations and a Quine Fellows program. Microsoft discusses possible later integration with other discovery products, without announcing general consumer access. Source